Acquisition of Advanced Medical Solutions Group plc (AMS) at a cash offer of 285 pence per share. Total Enterprise Value of the transaction is 715 million. The deal is structured as a court-sanctioned scheme of arrangement under the UK Companies Act 2006. Financing is 100% committed via bridge credit agreements with Goldman Sachs Bank USA, including term commitments of $1,386,713,188. The acquisition is expected to increase annual revenues by approximately $300 million. The transaction will create a new global business unit representing roughly 10% of combined revenues and EBITDA. Expected run-rate revenue and cost synergies are estimated at $55 million by 2031.